<?xml version="1.0" ?>
<document id="5484795b90c22596ead5f0b9ccf08d95a3e6f5c2">
  <chunk id="5484795b90c22596ead5f0b9ccf08d95a3e6f5c2.c0" text="In Vitro Reconstitution of SARS-Coronavirus mRNA Cap Methylation">
    <entity charOffset="44-48" id="5484795b90c22596ead5f0b9ccf08d95a3e6f5c2.c0.e0" ontology_id="CHEBI_33699" text="mRNA" type="chemical"/>
  </chunk>
  <chunk id="5484795b90c22596ead5f0b9ccf08d95a3e6f5c2.c1" text="SARS-coronavirus (SARS-CoV) genome expression depends on the synthesis of a set of mRNAs, which presumably are capped at their 59 end and direct the synthesis of all viral proteins in the infected cell. Sixteen viral non-structural proteins (nsp1 to nsp16) constitute an unusually large replicase complex, which includes two methyltransferases putatively involved in viral mRNA cap formation. The S-adenosyl-L-methionine (AdoMet)-dependent (guanine-N7)-methyltransferase (N7-MTase) activity was recently attributed to nsp14, whereas nsp16 has been predicted to be the AdoMet-dependent (nucleoside-29O)-methyltransferase. Here, we have reconstituted complete SARS-CoV mRNA cap methylation in vitro. We show that mRNA cap methylation requires a third viral protein, nsp10, which acts as an essential trigger to complete RNA cap-1 formation. The obligate sequence of methylation events is initiated by nsp14, which first methylates capped RNA transcripts to generate cap-0 7Me GpppA-RNAs. The latter are then selectively 29O-methylated by the 29O-MTase nsp16 in complex with its activator nsp10 to give rise to cap-1 7Me GpppA 29OMe -RNAs. Furthermore, sensitive in vitro inhibition assays of both activities show that aurintricarboxylic acid, active in SARS-CoV infected cells, targets both MTases with IC 50 values in the micromolar range, providing a validated basis for anti-coronavirus drug design.">
    <entity charOffset="172-180" id="5484795b90c22596ead5f0b9ccf08d95a3e6f5c2.c1.e0" ontology_id="CHEBI_36080" text="proteins" type="chemical"/>
    <entity charOffset="232-240" id="5484795b90c22596ead5f0b9ccf08d95a3e6f5c2.c1.e1" ontology_id="CHEBI_36080" text="proteins" type="chemical"/>
    <entity charOffset="373-377" id="5484795b90c22596ead5f0b9ccf08d95a3e6f5c2.c1.e2" ontology_id="CHEBI_33699" text="mRNA" type="chemical"/>
    <entity charOffset="397-420" id="5484795b90c22596ead5f0b9ccf08d95a3e6f5c2.c1.e3" ontology_id="CHEBI_15414" text="S-adenosyl-L-methionine" type="chemical"/>
    <entity charOffset="667-671" id="5484795b90c22596ead5f0b9ccf08d95a3e6f5c2.c1.e4" ontology_id="CHEBI_33699" text="mRNA" type="chemical"/>
    <entity charOffset="711-715" id="5484795b90c22596ead5f0b9ccf08d95a3e6f5c2.c1.e5" ontology_id="CHEBI_33699" text="mRNA" type="chemical"/>
    <entity charOffset="818-821" id="5484795b90c22596ead5f0b9ccf08d95a3e6f5c2.c1.e6" ontology_id="CHEBI_33697" text="RNA" type="chemical"/>
    <entity charOffset="936-939" id="5484795b90c22596ead5f0b9ccf08d95a3e6f5c2.c1.e7" ontology_id="CHEBI_33697" text="RNA" type="chemical"/>
    <entity charOffset="1388-1392" id="5484795b90c22596ead5f0b9ccf08d95a3e6f5c2.c1.e8" ontology_id="CHEBI_23888" text="drug" type="chemical"/>
  </chunk>
</document>
